查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830888

2025年机器人辅助经皮冠状动脉介入治疗（PCI）全球市场报告

Robot-Assisted Percutaneous Coronary Intervention (PCI) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，机器人辅助经皮冠状动脉介入治疗 (PCI) 市场规模呈指数级增长，从 2024 年的 195.9 亿美元增长至 2025 年的 275.6 亿美元，复合年增长率高达 40.7%。这段时期的成长主要得益于：支持机器人经皮经皮介入治疗的临床试验数量增加；相较于传统 PCI，机器人经皮冠状动脉介入治疗的成功率更高；医生机器人系统培训项目的不断扩展；偏好对先进治疗方案的偏好日益提升；以及发达地区报销政策的广泛普及。

机器人经皮经皮冠状动脉介入治疗 (PCI) 市场预计将在未来几年呈指数级增长，到 2029 年将达到 1068.6 亿美元，年复合成长率（CAGR）为 40.3%。预测期内的成长受到以下因素的推动：5G 和即时远端操作能力的日益融合、机器人经皮冠状动脉介入治疗系统向门诊手术中心的扩展、对减少 PCI 后住院时间的更加重视、创业投资对机器人心臟病学新兴企业的兴趣日益浓厚，以及机器学习在程序规划和指导中的应用日益广泛。预测期内的主要趋势包括开发用于即时资料共用的基于云端基础的机器人 PCI 平台、采用先进的网路安全措施来保护机器人程式资料、创建针对门诊心臟护理优化的机器人系统、人工智慧驱动的机器人从程式资料集中学习的创新，以及用于超精确冠状动脉导航的微型机器人工具的进步。

机器人辅助经皮冠状动脉介入治疗 (R-PCI) 是一种微创手术，利用机器人系统辅助引导导管、球囊和支架，以治疗狭窄或阻塞的冠状动脉。该技术提高了精准度、稳定性和可控性，减少了人为失误，同时最大限度地减少了患者和医护人员的辐射暴露。该方法旨在提高手术安全性、效率和整体临床疗效。

机器人辅助PCI的主要组件包括机器人系统、导管和导管导引线以及主机。机器人系统是一种先进的机器，可让医生从受保护的工作站远端操纵导管导引线、球囊和支架。 R-PCI用于冠状动脉血管成形术、支架置入术和血栓切除术等手术，服务于医院、心导管实验室、门诊手术中心和其他医疗机构等终端用户。

美国关税的快速上涨以及随之而来的始于2025年春季的贸易摩擦，对医疗设备行业产生了重大影响，尤其对进口诊断影像设备零件、手术用不銹钢和塑胶耗材产生了重大影响。医院和诊所抵制涨价，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要设备重新认证，从而延缓了产品上市时间。企业正在透过双重采购关键零件、扩大国内商品化生产以及加快高性价比材料的研发来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供机器人辅助经皮冠状动脉介入治疗 (PCI) 市场统计数据，包括经皮市场规模、区域份额、机器人经皮经皮冠状动脉介入治疗 (PCI) 市场份额竞争对手、详细的机器人辅助经皮冠状动脉介入治疗 (PCI) 市场、市场、市场和机械市场成功机器人辅助经经皮冠状动脉介入治疗 (PCI) 市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的一切资讯的完整展望。

心血管疾病盛行率的上升预计将在未来几年推动机器人辅助经皮冠状动脉介入治疗 (PCI) 市场的成长。心血管疾病包括影响心臟和血管的各种疾病，包括冠状动脉疾病、心臟病发作和中风。这种增长主要是由于肥胖、高血压和久坐不动的生活方式导致的心臟健康不佳。机器人辅助经皮冠状动脉介入治疗 (PCI) 透过精确地重新打开冠状动脉中的阻塞和狭窄，恢復心臟的血流，同时最大限度地降低手术风险和放射暴露并改善患者的预后来解决这些疾病。例如，根据美国心臟协会的数据，2024 年 1 月美国主要与高血压相关的死亡人数为 131,454 人，高于 2021 年的 124,508 人。因此，心血管疾病盛行率的上升正在推动机器人辅助 PCI 市场的扩张。

机器人辅助经皮冠状动脉介入治疗 (PCI) 市场的主要企业正在投资先进的机器人心臟病学平台，以增强患者安全性并简化复杂的冠状动脉手术。机器人心臟病学平台是一套先进的系统，可协助心臟科医师进行精准且可控的冠状动脉介入治疗，提高准确性，减少人为错误，并最大限度地减少患者和医务人员的辐射暴露。例如，2023 年 5 月，专注于机器人血管介入解决方案的法国公司 Robocath SAS 推出了 R-One+。这款先进的机器人系统使介入性心臟病专家能够透过导管室或控制室中的整合指令单元操作设备来执行 PCI 手术。 R-One+ 透过提高设备操作精度和减少辐射暴露来增强患者和工作人员的安全性，为操作人员提供更舒适的工作环境。 R-One+ 在巴黎举行的 EuroPCR 会议上亮相，重点介绍了其新功能，这些功能可使 PCI 手术更安全、更有效率，同时保护心臟病学团队免受辐射损伤。此次发布彰显了 Robocus 致力于透过智慧机器人辅助推动心血管疾病治疗的决心。

2022年7月，总部位于爱尔兰的机器人辅助手术设备供应商Medtronic( Medtronic Plc) 与 CathWorks 合作，透过人工智慧主导的非侵入性诊断技术革新冠状动脉治疗。此次合作旨在利用 CathWorks 基于人工智慧的 FFRangio 系统改善冠状动脉疾病的诊断和治疗，从而实现更快、更可靠、非侵入性的临床决策。总部位于以色列的 CathWorks 提供了一个人工智慧平台，旨在彻底改变心血管疾病的诊断和管理。

机器人经皮经皮冠状动脉介入治疗 (PCI) 市场由提供机器人导管导航、远端支架置入、即时影像整合和手术计画支援等服务的营业单位所获得的收益构成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关商品的价值。机器人经皮经皮冠状动脉介入治疗 (PCI) 市场还包括辐射屏蔽配件、机械臂组件、监测和显示单元、整合介面和无菌抛弃式套件的销售。此市场的价值代表“出厂价”，即商品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球机器人经皮经皮冠状动脉介入治疗（PCI）：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球机器人经皮经皮冠状动脉介入治疗（PCI）市场：成长率分析
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场表现：规模与成长，2019-2024 年
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场预测：规模与成长，2024-2029 年，2034 年
  • 全球机器人经皮经皮冠状动脉介入治疗（PCI）：总目标市场（TAM）

第六章 市场细分

  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：按组件、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 机器人系统
  • 导管和导管导引线
  • 主机
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 冠状动脉成形术
  • 支架置入
  • 血栓切除术
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 心导管实验室
  • 门诊手术中心
  • 其他最终用户
  • 全球机器人辅助经皮冠状动脉介入治疗 (PCI) 市场：按机器人系统（类型）细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 电子机械机器人机械臂
  • 成像整合单元
  • 机器人驱动系统
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：导管和导管导引线细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 冠状动脉导管导引线
  • 球囊导管
  • 药物释放型导管
  • 全球机器人辅助经皮冠状动脉介入治疗 (PCI) 市场：按主机细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 触控萤幕介面
  • 摇桿控制器
  • 影像显示面板

第七章 区域和国家分析

  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：区域分析、预测与趋势（2019-2024 年、2024-2029 年及 2034 年）
  • 全球机器人经皮经皮冠状动脉介入治疗 (PCI) 市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 机器人辅助经皮冠状动脉介入治疗（PCI）市场：竞争格局
  • 机器人辅助经皮冠状动脉介入治疗（PCI）市场：公司简介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Intuitive Surgical Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • BIOTRONIK SE & Co. KG
  • MicroPort Scientific Corporation
  • Biosensors International Group Ltd.
  • OrbusNeich Medical Group Holdings Limited
  • Medical Microinstruments
  • Quantum Surgical
  • Stereotaxis Inc.
  • THINK Surgical Inc.
  • Perfint Healthcare
  • Robocath Inc.
  • SS Innovations
  • Auris Health
  • EP Solutions SA
  • NDR Medical Technology
  • Meril Life Sciences Pvt. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年机器人辅助经皮冠状动脉介入治疗（PCI）市场：提供新机会的国家
  • 2029年机器人辅助经皮冠状动脉介入治疗（PCI）市场：细分市场带来新机会
  • 机器人辅助经皮冠状动脉介入治疗 (PCI) 市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37879

Robot-assisted percutaneous coronary intervention (R-PCI) is a minimally invasive procedure in which robotic systems help navigate catheters, balloons, and stents to treat narrowed or blocked coronary arteries. This technology enhances precision, stability, and control, reducing human error while also minimizing radiation exposure for both patients and healthcare staff. The approach aims to improve procedural safety, efficiency, and overall clinical outcomes.

The primary components of robot-assisted PCI include robotic systems, catheters and guidewires, and control consoles. Robotic systems are advanced machines that enable physicians to remotely manipulate guidewires, balloons, and stents from a protected workstation. R-PCI is utilized in procedures such as coronary angioplasty, stent placement, and thrombectomy, and serves end users including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The robot-assisted percutaneous coronary intervention (PCI) market research report is one of a series of new reports from The Business Research Company that provides robot-assisted percutaneous coronary intervention (PCI) market statistics, including robot-assisted percutaneous coronary intervention (PCI) industry global market size, regional shares, competitors with a robot-assisted percutaneous coronary intervention (PCI) market share, detailed robot-assisted percutaneous coronary intervention (PCI) market segments, market trends and opportunities, and any further data you may need to thrive in the robot-assisted percutaneous coronary intervention (PCI) industry. The robot-assisted percutaneous coronary intervention (PCI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robot-assisted percutaneous coronary intervention (PCI) market size has grown exponentially in recent years. It will grow from $19.59 billion in 2024 to $27.56 billion in 2025 at a compound annual growth rate (CAGR) of 40.7%. The growth in the historic period can be attributed to the increasing number of clinical trials supporting robotic percutaneous coronary intervention, higher procedural success rates compared to conventional PCI, expansion of physician training programs for robotic systems, rising patient preference for advanced treatment options, and broader availability of reimbursement policies in developed regions.

The robot-assisted percutaneous coronary intervention (PCI) market size is expected to see exponential growth in the next few years. It will grow to $106.86 billion in 2029 at a compound annual growth rate (CAGR) of 40.3%. The growth in the forecast period can be attributed to the increasing integration of 5G and real-time remote operation capabilities, expansion of robotic percutaneous coronary intervention systems into ambulatory surgical centers, heightened focus on reducing hospital stays post-PCI, rising venture capital interest in robotic cardiology startups, and growing incorporation of machine learning for procedural planning and guidance. Major trends in the forecast period include development of cloud-based robotic PCI platforms for real-time data sharing, implementation of advanced cybersecurity measures to protect robotic procedural data, creation of robotic systems optimized for outpatient cardiac care, innovation in AI-powered robotic learning from procedural datasets, and advancement of miniaturized robotic tools for ultra-precise coronary navigation.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the robot-assisted percutaneous coronary intervention (PCI) market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. This increase is primarily attributed to sedentary lifestyles, resulting in obesity, hypertension, and poor heart health. Robot-assisted percutaneous coronary intervention (PCI) addresses these conditions by precisely reopening blocked or narrowed coronary arteries to restore blood flow to the heart while minimizing procedural risks and radiation exposure, thereby improving patient outcomes. For example, according to the American Heart Association, in January 2024, there were 131,454 deaths in the U.S. primarily linked to high blood pressure in 2022, up from 124,508 deaths in 2021. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the robot-assisted PCI market.

Leading companies in the robot-assisted percutaneous coronary intervention (PCI) market are investing in advanced robotic cardiology platforms to enhance patient safety and simplify complex coronary procedures. A robotic cardiology platform is a sophisticated system that assists cardiologists in performing precise and controlled coronary interventions while improving accuracy, reducing human error, and minimizing radiation exposure for both patients and medical personnel. For instance, in May 2023, Robocath SAS, a France-based firm specializing in robotic vascular intervention solutions, launched the R-One+. This cutting-edge robotic system allows interventional cardiologists to perform coronary angioplasties (PCI) by operating devices via an integrated command unit in the catheterization lab or control room. The R-One+ boosts precision in device handling, enhances safety for patients and staff by lowering radiation exposure, and provides more comfortable working conditions for operators. Its unveiling at the EuroPCR conference in Paris highlighted new capabilities that make PCI procedures safer and more efficient while protecting the cardiology team from radiation-related injuries. This launch underscores Robocath's dedication to advancing cardiovascular disease treatment through intelligent robotic assistance.

In July 2022, Medtronic Plc, an Ireland-based company offering robotic-assisted surgical devices, partnered with CathWorks to transform coronary care through AI-driven, non-invasive diagnostics. The collaboration seeks to improve the diagnosis and treatment of coronary artery disease using CathWorks' AI-based FFRangio system, enabling faster, more reliable, and non-invasive clinical decision-making. CathWorks, an Israel-based company, provides an artificial intelligence-enabled platform designed to revolutionize cardiovascular disease diagnosis and management.

Major players in the robot-assisted percutaneous coronary intervention (pci) market are Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Intuitive Surgical, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Group Holdings Limited, Medical Microinstruments, Quantum Surgical, Stereotaxis Inc., THINK Surgical Inc., Perfint Healthcare, Robocath Inc., SS Innovations, Auris Health, EP Solutions SA, NDR Medical Technology, Meril Life Sciences Pvt. Ltd.

North America was the largest region in the robot-assisted percutaneous coronary intervention (PCI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in robot-assisted percutaneous coronary intervention (PCI) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the robot-assisted percutaneous coronary intervention (PCI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robot-assisted percutaneous coronary intervention (PCI) market consists of revenues earned by entities by providing services such as robotic catheter navigation, remote-controlled stent placement, real-time imaging integration, and procedural planning support. The market value includes the value of related goods sold by the service provider or included within the service offering. The robot-assisted percutaneous coronary intervention (PCI) market also includes sales of radiation shielding accessories, robotic arm components, monitoring and display units, integration interfaces, and sterile disposable kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Robot-Assisted Percutaneous Coronary Intervention (PCI) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on robot-assisted percutaneous coronary intervention (pci) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for robot-assisted percutaneous coronary intervention (pci) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robot-assisted percutaneous coronary intervention (pci) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Robotic Systems; Catheters And Guidewires; Control Consoles
  • 2) By Application: Coronary Angioplasty; Stent Placement; Thrombectomy
  • 3) By End-User: Hospitals; Cardiac Catheterization Laboratories; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Robotic Systems: Electromechanical Robotic Arms; Imaging Integration Units; Robotic Drive Systems
  • 2) By Catheters And Guidewires: Coronary Guidewires; Balloon Catheters; Drug-Eluting Catheters
  • 3) By Control Consoles: Touchscreen Interfaces; Joystick Controllers; Imaging Display Panels
  • Companies Mentioned: Medtronic plc; Siemens Healthineers AG; Stryker Corporation; Boston Scientific Corporation; Intuitive Surgical; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Biosensors International Group Ltd.; OrbusNeich Medical Group Holdings Limited; Medical Microinstruments; Quantum Surgical; Stereotaxis Inc.; THINK Surgical Inc.; Perfint Healthcare; Robocath Inc.; SS Innovations; Auris Health; EP Solutions SA; NDR Medical Technology; Meril Life Sciences Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Characteristics

3. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Trends And Strategies

4. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Growth Rate Analysis
  • 5.4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Total Addressable Market (TAM)

6. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Segmentation

  • 6.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Robotic Systems
  • Catheters And Guidewires
  • Control Consoles
  • 6.2. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Angioplasty
  • Stent Placement
  • Thrombectomy
  • 6.3. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Robotic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electromechanical Robotic Arms
  • Imaging Integration Units
  • Robotic Drive Systems
  • 6.5. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Catheters And Guidewires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Guidewires
  • Balloon Catheters
  • Drug-Eluting Catheters
  • 6.6. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Sub-Segmentation Of Control Consoles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Touchscreen Interfaces
  • Joystick Controllers
  • Imaging Display Panels

7. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Regional And Country Analysis

  • 7.1. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 8.1. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 9.1. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 9.2. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 10.1. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 11.1. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 11.2. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 12.1. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 13.1. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 14.1. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 14.2. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 15.1. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 15.2. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 16.1. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 17.1. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 18.1. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 19.1. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 20.1. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 21.1. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 21.2. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 22.1. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 23.1. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 23.2. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 24.1. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 24.2. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 25.1. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 25.2. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 26.1. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 26.2. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 27.1. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 28.1. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 28.2. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

  • 29.1. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Overview
  • 29.2. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Robot-Assisted Percutaneous Coronary Intervention (PCI) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Landscape And Company Profiles

  • 30.1. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Landscape
  • 30.2. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Intuitive Surgical Overview, Products and Services, Strategy and Financial Analysis

31. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Other Major And Innovative Companies

  • 31.1. BIOTRONIK SE & Co. KG
  • 31.2. MicroPort Scientific Corporation
  • 31.3. Biosensors International Group Ltd.
  • 31.4. OrbusNeich Medical Group Holdings Limited
  • 31.5. Medical Microinstruments
  • 31.6. Quantum Surgical
  • 31.7. Stereotaxis Inc.
  • 31.8. THINK Surgical Inc.
  • 31.9. Perfint Healthcare
  • 31.10. Robocath Inc.
  • 31.11. SS Innovations
  • 31.12. Auris Health
  • 31.13. EP Solutions SA
  • 31.14. NDR Medical Technology
  • 31.15. Meril Life Sciences Pvt. Ltd.

32. Global Robot-Assisted Percutaneous Coronary Intervention (PCI) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

34. Recent Developments In The Robot-Assisted Percutaneous Coronary Intervention (PCI) Market

35. Robot-Assisted Percutaneous Coronary Intervention (PCI) Market High Potential Countries, Segments and Strategies

  • 35.1 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Robot-Assisted Percutaneous Coronary Intervention (PCI) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer